Common Stock Dark or Defunct
OTC Pink No Information
Contact Info
  • 2000 Hamilton Street
  • Suite 204
  • Philadelphia, PA 19130

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Mar 31, 2009
Audited Financials Not Available
Latest Report Sep 30, 2008 10-Q
CIK 0001015441
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 1996
Employees Not Available
Company Officers/Contacts
Adele Sommerfeld CEO
Company Directors
Andy Dahl Chairman
Bruno Maruzzo
Serge Morrell
Company Notes
  • Note=12-99 company is a development stage biopharmaceutical company acquiring & developing technologies and products for the treatment of cancer and other life-threatening diseases
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
AVXT Security Details
Share Structure
Market Value1 $926,937 a/o Oct 21, 2016
Authorized Shares Not Available
Outstanding Shares 142,605,753 a/o Apr 27, 2007
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.004
Shareholders of Record 4,000 a/o Apr 15, 2008
Short Selling Data
Short Interest 25,000 (635.29%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security